The DOI matches its Crossref record; 88 of the 88 references it cites were found in a registry or an index.
Ionizing Radiation-Induced DNA Damage, Response, and Repair
Abstract
SIGNIFICANCE: Ionizing radiation (IR) is an effective and commonly employed treatment in the management of more than half of human malignancies. Because IR's ability to control tumors mainly relies on DNA damage, the cell's DNA damage response and repair (DRR) processes may hold the key to determining tumor responses. IR-induced DNA damage activates a number of DRR signaling cascades that control cell cycle arrest, DNA repair, and the cell's fate. DNA double-strand breaks (DSBs) generated by IR are the most lethal form of damage, and are mainly repaired via either homologous recombination (HR) or nonhomologous end-joining (NHEJ) pathways. RECENT ADVANCES: In recent years, immense effort to understand and exploit the differences in the use of these repair pathways between tumors and normal cells will allow for an increase in tumor cell killing and a decrease in normal tissue injury. CRITICAL ISSUES: Regulation of the two major DSB repair mechanisms (HR and NHEJ) and new strategies, which may improve the therapeutic ratio of radiation by differentially targeting HR and NHEJ function in tumor and normal tissues, is of intense interest currently, and is the focus of this article. FUTURE DIRECTIONS: By utilizing the strategies outlined above, it may be possible to exploit differences between tumor and somatic cell DRR pathways, specifically their DSB repair mechanisms, to improve the therapeutic ratio of IR.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy
Farmer, H., McCabe, N., Lord, C. J., Tutt, A. N. J., Johnson, D. A., Richardson, T. B., Santarosa, M., Dillon, K. J., Hickson, I., Knights, C., et al. (2005) · Nature · doi:10.1038/nature03445 · Cited by 6,683
Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase
Bryant, H. E., Schultz, N., Thomas, H. D., Parker, K. M., Flower, D., Lopez, E., Kyle, S., Meuth, M., Curtin, N. J., & Helleday, T. (2005) · Nature · doi:10.1038/nature03443 · Cited by 5,198
Inhibition of Poly(ADP-Ribose) Polymerase in Tumors from BRCA Mutation Carriers
Fong, P. C., Boss, D. S., Yap, T. A., Tutt, A., Wu, P., Mergui-Roelvink, M., Mortimer, P., Swaisland, H., Lau, A., O'Connor, M. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0900212 · Cited by 3,634
GSK-3: tricks of the trade for a multi-tasking kinase
Doble, B. W., & Woodgett, J. R. (2003) · Journal of Cell Science · doi:10.1242/jcs.00384 · Cited by 2,084
The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer
Vermeulen, K., Van Bockstaele, D. R., & Berneman, Z. N. (2003) · Cell Proliferation · doi:10.1046/j.1365-2184.2003.00266.x · Cited by 1,773
Delaney, G., Jacob, S., Featherstone, C., & Barton, M. (2005) · Cancer · doi:10.1002/cncr.21324 · Cited by 1,727
Chk1 and Chk2 kinases in checkpoint control and cancer
Bartek, J., & Lukas, J. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00110-7 · Cited by 1,513
Ward, J. F. (1988) · Progress in Nucleic Acid Research and Molecular Biology · doi:10.1016/s0079-6603(08)60611-x · Cited by 1,492
Amé, J., Spenlehauer, C., & de Murcia, G. (2004) · BioEssays · doi:10.1002/bies.20085 · Cited by 1,459
The ATM–Chk2 and ATR–Chk1 Pathways in DNA Damage Signaling and Cancer
(2010) · Advances in Cancer Research · doi:10.1016/b978-0-12-380888-2.00003-0 · Cited by 1,276
G1 cell-cycle control and cancer
Massagué, J. (2004) · Nature · doi:10.1038/nature03094 · Cited by 1,224
Wang, Y., Cortez, D., Yazdi, P., Neff, N., Elledge, S. J., & Qin, J. (2000) · Genes & Development · doi:10.1101/gad.14.8.927 · Cited by 1,221 · cited 1×
“HR repair is activated, in part, by the presence of single-stranded DNA generated by resection from the DSB ends and requires CtIP and Mre11 proteins (17, 75, 77).”
Structure of the Ku heterodimer bound to DNA and its implications for double-strand break repair
Walker, J. R., Corpina, R. A., & Goldberg, J. (2001) · Nature · doi:10.1038/35088000 · Cited by 1,212
Ma, Y., Pannicke, U., Schwarz, K., & Lieber, M. R. (2002) · Cell · doi:10.1016/s0092-8674(02)00671-2 · Cited by 1,166
Strategies to improve radiotherapy with targeted drugs
Begg, A. C., Stewart, F. A., & Vens, C. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3007 · Cited by 1,118
Requirement of the MRN complex for ATM activation by DNA damage
Uziel, T., Lerenthal, Y., Moyal, L., Andegeko, Y., Mittelman, L., & Shiloh, Y. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg541 · Cited by 1,075
ATM- and cell cycle-dependent regulation of ATR in response to DNA double-strand breaks
Jazayeri, A., Falck, J., Lukas, C., Bartek, J., Smith, G. C. M., Lukas, J., & Jackson, S. P. (2006) · Nature Cell Biology · doi:10.1038/ncb1337 · Cited by 1,064
Mechanism and regulation of human non-homologous DNA end-joining
Lieber, M. R., Ma, Y., Pannicke, U., & Schwarz, K. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1202 · Cited by 973
Mitotic homologous recombination maintains genomic stability and suppresses tumorigenesis
Moynahan, M. E., & Jasin, M. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2851 · Cited by 930
Multiple Roles of the PI3K/PKB (Akt) Pathway in Cell Cycle Progression
Liang, J., & Slingerland, J. M. (2003) · Cell Cycle · doi:10.4161/cc.2.4.433 · Cited by 885
Normal tissue reactions to radiotherapy: towards tailoring treatment dose by genotype
Barnett, G. C., West, C. M. L., Dunning, A. M., Elliott, R. M., Coles, C. E., Pharoah, P. D. P., & Burnet, N. G. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2587 · Cited by 771
Comparison of nonhomologous end joining and homologous recombination in human cells
MAO, Z., BOZZELLA, M., SELUANOV, A., & GORBUNOVA, V (2008) · DNA Repair · doi:10.1016/j.dnarep.2008.06.018 · Cited by 671
The roles of BRCA1 and BRCA2 and associated proteins in the maintenance of genomic stability
Gudmundsdottir, K., & Ashworth, A. (2006) · Oncogene · doi:10.1038/sj.onc.1209874 · Cited by 622
Chapman, J. R., Barral, P., Vannier, J.-B., Borel, V., Steger, M., Tomas-Loba, A., Sartori, A. A., Adams, I. R., Batista, F. D., & Boulton, S. J. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.01.002 · Cited by 606
53BP1 Regulates DSB Repair Using Rif1 to Control 5′ End Resection
Zimmermann, M., Lottersberger, F., Buonomo, S. B., Sfeir, A., & de Lange, T. (2013) · Science · doi:10.1126/science.1231573 · Cited by 603
CtIP-BRCA1 modulates the choice of DNA double-strand-break repair pathway throughout the cell cycle
Yun, M. H., & Hiom, K. (2009) · Nature · doi:10.1038/nature07955 · Cited by 556
Activation and regulation of ATM kinase activity in response to DNA double-strand breaks
Lee, J.-H., & Paull, T. T. (2007) · Oncogene · doi:10.1038/sj.onc.1210872 · Cited by 545 · cited 3×
“Similarly, the serine/threonine-specific kinase ATM is activated by the presence of DNA DSBs (44).”
Cdc25 Mitotic Inducer Targeted by Chk1 DNA Damage Checkpoint Kinase
Furnari, B., Rhind, N., & Russell, P. (1997) · Science · doi:10.1126/science.277.5331.1495 · Cited by 539
Functional interactions between BRCA1 and the checkpoint kinase ATR during genotoxic stress
Tibbetts, R. S., Cortez, D., Brumbaugh, K. M., Scully, R., Livingston, D., Elledge, S. J., & Abraham, R. T. (2000) · Genes & Development · doi:10.1101/gad.851000 · Cited by 512
Essential and dispensable roles of ATR in cell cycle arrest and genome maintenance
Brown, E. J., & Baltimore, D. (2003) · Genes & Development · doi:10.1101/gad.1067403 · Cited by 511
BRCA1 regulates the G2/M checkpoint by activating Chk1 kinase upon DNA damage
Yarden, R. I., Pardo-Reoyo, S., Sgagias, M., Cowan, K. H., & Brody, L. C. (2002) · Nature Genetics · doi:10.1038/ng837 · Cited by 484
Factors determining DNA double‐strand break repair pathway choice in G2 phase
Shibata, A., Conrad, S., Birraux, J., Geuting, V., Barton, O., Ismail, A., Kakarougkas, A., Meek, K., Taucher‐Scholz, G., Löbrich, M., et al. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.27 · Cited by 479
Dasika, G. K., Lin, S.-C. J., Zhao, S., Sung, P., Tomkinson, A., & Lee, E. Y.-H. P. (1999) · Oncogene · doi:10.1038/sj.onc.1203283 · Cited by 427
Chen, L., Nievera, C. J., Lee, A. Y.-L., & Wu, X. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m710245200 · Cited by 424
The endless tale of non-homologous end-joining
Weterings, E., & Chen, D. J. (2008) · Cell Research · doi:10.1038/cr.2008.3 · Cited by 418
Yeast DNA ligase IV mediates non-homologous DNA end joining
Wilson, T. E., Grawunder, U., & Lieber, M. R. (1997) · Nature · doi:10.1038/41365 · Cited by 417
Mechanisms of DNA double strand break repair and chromosome aberration formation
Iliakis, G., Wang, H., Perrault, A. R., Boecker, W., Rosidi, B., Windhofer, F., Wu, W., Guan, J., Terzoudi, G., & Pantelias, G. (2004) · Cytogenetic and Genome Research · doi:10.1159/000077461 · Cited by 396
Radiation-induced neuropathy in cancer survivors
Delanian, S., Lefaix, J.-L., & Pradat, P.-F. (2012) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2012.10.012 · Cited by 376
Zou, Y., Liu, Y., Wu, X., & Shell, S. M. (2006) · Journal of Cellular Physiology · doi:10.1002/jcp.20622 · Cited by 368
Powell, S. N., & Kachnic, L. A. (2003) · Oncogene · doi:10.1038/sj.onc.1206678 · Cited by 364
G2 checkpoint abrogation and checkpoint kinase-1 targeting in the treatment of cancer
Bucher, N., & Britten, C. D. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604208 · Cited by 349
The ATM protein kinase and cellular redox signaling: beyond the DNA damage response
Ditch, S., & Paull, T. T. (2012) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2011.10.002 · Cited by 324
Chk2 Phosphorylation of BRCA1 Regulates DNA Double-Strand Break Repair
Zhang, J., Willers, H., Feng, Z., Ghosh, J. C., Kim, S., Weaver, D. T., Chung, J. H., Powell, S. N., & Xia, F. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.2.708-718.2004 · Cited by 323
Self-citationA synthetic lethal siRNA screen identifying genes mediating sensitivity to a PARP inhibitor
Turner, N. C., Lord, C. J., Iorns, E., Brough, R., Swift, S., Elliott, R., Rayter, S., Tutt, A. N., & Ashworth, A. (2008) · The EMBO Journal · doi:10.1038/emboj.2008.61 · Cited by 322
RIF1 Counteracts BRCA1-mediated End Resection during DNA Repair
Feng, L., Fong, K.-W., Wang, J., Wang, W., & Chen, J. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.457440 · Cited by 272
Spagnolo, L., Rivera-Calzada, A., Pearl, L. H., & Llorca, O. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.04.013 · Cited by 270
Wang, H., Shi, L. Z., Wong, C. C. L., Han, X., Hwang, P. Y.-H., Truong, L. N., Zhu, Q., Shao, Z., Chen, D. J., Berns, M. W., et al. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003277 · Cited by 259
The ATM–p53 pathway suppresses aneuploidy-induced tumorigenesis
Li, M., Fang, X., Baker, D. J., Guo, L., Gao, X., Wei, Z., Han, S., van Deursen, J. M., & Zhang, P. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1005960107 · Cited by 257
Fattah, F., Lee, E. H., Weisensel, N., Wang, Y., Lichter, N., & Hendrickson, E. A. (2010) · PLoS Genetics · doi:10.1371/journal.pgen.1000855 · Cited by 244
A review of PARP inhibitors: from bench to bedside
Underhill, C., Toulmonde, M., & Bonnefoi, H. (2011) · Annals of Oncology · doi:10.1093/annonc/mdq322 · Cited by 240
Role of DNA–PK in the cellular response to DNA double-strand breaks
Burma, S., & Chen, D. J. (2004) · DNA Repair · doi:10.1016/j.dnarep.2004.03.021 · Cited by 219
PI3K/PTEN/AKT pathway. A critical mediator of oncogenic signaling.
Paez, J., & Sellers, W. R. (2003) · PubMed · Cited by 213
Ou, Y.-H., Chung, P.-H., Sun, T.-P., & Shieh, S.-Y. (2005) · Molecular Biology of the Cell · doi:10.1091/mbc.e04-08-0689 · Cited by 198
Atm selectively regulates distinct p53-dependent cell-cycle checkpoint and apoptotic pathways
Barlow, C., Brown, K. D., Deng, C.-X., Tagle, D. A., & Wynshaw-Boris, A. (1997) · Nature Genetics · doi:10.1038/ng1297-453 · Cited by 197
Gatei, M., Zhou, B.-B., Hobson, K., Scott, S., Young, D., & Khanna, K. K. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m011681200 · Cited by 191
Lithium Treatment Prevents Neurocognitive Deficit Resulting from Cranial Irradiation
Yazlovitskaya, E. M., Edwards, E., Thotala, D., Fu, A., Osusky, K. L., Whetsell, W. O., Boone, B., Shinohara, E. T., & Hallahan, D. E. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-2740 · Cited by 187
Knobbe, C. B., Merlo, A., & Reifenberger, G. (2002) · Neuro-Oncology · doi:10.1093/neuonc/4.3.196 · Cited by 186
Signaling Pathways that Regulate Cell Division
Rhind, N., & Russell, P. (2012) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a005942 · Cited by 186
Paez, J., & Sellers, W. R. (2006) · Cancer Treatment and Research · doi:10.1007/0-306-48158-8_6 · Cited by 180
DNA Repair and Resistance of Gliomas to Chemotherapy and Radiotherapy
Frosina, G. (2009) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-09-0030 · Cited by 180
XRCC3 Controls the Fidelity of Homologous Recombination
Brenneman, M. A., Wagener, B. M., Miller, C. A., Allen, C., & Nickoloff, J. A. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00595-6 · Cited by 176
GSK3β Regulates Differentiation and Growth Arrest in Glioblastoma
Korur, S., Huber, R. M., Sivasankaran, B., Petrich, M., Morin, P., Hemmings, B. A., Merlo, A., & Lino, M. M. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007443 · Cited by 176
DNA polymerase Family X: Function, structure, and cellular roles
Yamtich, J., & Sweasy, J. B. (2010) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2009.07.008 · Cited by 175
Maloisel, L., Fabre, F., & Gangloff, S. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01651-07 · Cited by 174
Halicka, H. D., Huang, X., Traganos, F., King, M. A., Dai, W. H., & Darżynkiewicz, Z. (2004) · Cell Cycle · doi:10.4161/cc.4.2.1486 · Cited by 151
Knobbe-Thomsen, C. B. (2002) · Neuro-Oncology · doi:10.1215/15228517-4-3-196 · Cited by 146
Li, L., Wang, H., Yang, E. S.-H., Arteaga, C. L., & Xia, F. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1127 · Cited by 131
Self-citationPelvic Radiotherapy and Sexual Function in Men and Women
Incrocci, L., & Jensen, P. T. (2013) · The Journal of Sexual Medicine · doi:10.1111/jsm.12010 · Cited by 118
Efimova, E. V., Mauceri, H. J., Golden, D. W., Labay, E., Bindokas, V. P., Darga, T. E., Chakraborty, C., Barreto-Andrade, J. C., Crawley, C. D., Sutton, H. G., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4224 · Cited by 118
Recruitment of ATM Protein to Double Strand DNA Irradiated with Ionizing Radiation
Suzuki, K., Kodama, S., & Watanabe, M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.36.25571 · Cited by 117
The DNA-dependent protein kinase (DNA-PK): More than just a case of making ends meet?
Hill, R., & Lee, P. W. K. (2010) · Cell Cycle · doi:10.4161/cc.9.17.13043 · Cited by 115
The DNA damage checkpoint response to replication stress: A Game of Forks
Jossen, R., & Bermejo, R. (2013) · Frontiers in Genetics · doi:10.3389/fgene.2013.00026 · Cited by 106
May, K., & Hardwick, K. (2006) · Journal of Cell Science · doi:10.1242/jcs.03165 · Cited by 100
Moll, U. M., Lau, R., Sypes, M. A., Gupta, M., & Anderson, C. W. (1999) · Oncogene · doi:10.1038/sj.onc.1202640 · Cited by 94
DNA end-independent activation of DNA-PK mediated via association with the DNA-binding protein C1DPreprint
Yavuzer, U., Smith, G. C. M., Bliss, T. M., Werner, D., & Jackson, S. P. (1998) · Genes & Development · doi:10.1101/gad.12.14.2188 · Cited by 75
The multiple facets of the intra-S checkpoint
Grallert, B., & Boye, E. (2008) · Cell Cycle · doi:10.4161/cc.6389 · Cited by 73
Nur‐E‐Kamal, A., Li, T., Zhang, A., Qi, H., Hars, E. S., & Liu, L. F. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212915200 · Cited by 60
Clinical relevance of the homologous recombination machinery in cancer therapy
Miyagawa, K. (2007) · Cancer Science · doi:10.1111/j.1349-7006.2007.00644.x · Cited by 59
Wang, H., Yang, E. S.-H., Jiang, J., Nowsheen, S., & Xia, F. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4713 · Cited by 58
Self-citationYang, E. S.-H., Wang, H., Jiang, G., Nowsheen, S., Fu, A., Hallahan, D. E., & Xia, F. (2009) · Journal of Clinical Investigation · doi:10.1172/jci34051 · Cited by 55
Self-citationNew insights on the molecular and cell biology of human cholangiopathies
Alvaro, D., & Mancino, M. G. (2007) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2007.09.007 · Cited by 48
Yang, E. S.-H., Nowsheen, S., Wang, T., Thotala, D. K., & Xia, F. (2011) · Neuro-Oncology · doi:10.1093/neuonc/nor016 · Cited by 48
Self-citationKhan, H. A., & Alhomida, A. S. (2011) · Journal of Applied Toxicology · doi:10.1002/jat.1716 · Cited by 43
PARP Inhibitors in BRCA Gene-Mutated Ovarian Cancer and Beyond
Banerjee, S. N., & Kaye, S. B. (2011) · Current Oncology Reports · doi:10.1007/s11912-011-0193-9 · Cited by 43
Della-Maria, J., Motycka, T. A., Han, M., Jasin, M., & Tomkinson, A. E. (2005) · DNA repair · doi:10.1016/j.dnarep.2005.02.004 · Cited by 32
Bae, J. S., Roh, J., Lee, S.-W., Kim, S., Kim, J. S., Lee, J. H., Choi, S., Nam, S. Y., & Kim, S. Y. (2012) · Oral Oncology · doi:10.1016/j.oraloncology.2012.02.023 · Cited by 30
LEE, J. H., KIM, K. H., MORIO, T., & KIM, H. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1378.056 · Cited by 14 · cited 1×
“ATM has been demonstrated to also phosphorylate and activate Ku in response to DNA damage (45).”
(1995) · PubMed
Cited by
DNA damage response signaling pathways and targets for radiotherapy sensitization in cancer
Huang, R.-X., & Zhou, P.-K. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0150-x · Cited by 1,198
Lee, S. Y., Jeong, E. K., Ju, M. K., Jeon, H. M., Kim, M. Y., Kim, C. H., Park, H. G., Han, S. I., & Kang, H. S. (2017) · Molecular Cancer · doi:10.1186/s12943-016-0577-4 · Cited by 578
Neutrophil‐Based Drug Delivery Systems
Chu, D., Dong, X., Shi, X., Zhang, C., & Wang, Z. (2018) · Advanced Materials · doi:10.1002/adma.201706245 · Cited by 386
Cellular functions of the protein kinase ATM and their relevance to human disease
Lee, J.-H., & Paull, T. T. (2021) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-021-00394-2 · Cited by 289
FLASH Radiotherapy: Current Knowledge and Future Insights Using Proton-Beam Therapy
Hughes, J. R., & Parsons, J. L. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186492 · Cited by 267
Metadata
- Authors
- Santivasi, W. L., & Xia, F.
- Venue
- Antioxidants & Redox Signaling
- Publisher
- SAGE Publications
- Published
- 2014-07-10
- Volume
- 21
- Issue
- 2
- Pages
- 251-259
- ISSN
- 1523-0864 (ISSN-L)
- 1557-7716
- OpenAlex
- W1780348968
- Cited by
- 593
- References
- 88
- FWCI
- 4.17
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.